Advertisement

Topics

French pharma group Ipsen sees more asset purchases, U.S. growth

02:23 EST 15 Feb 2018 | Reuters

PARIS (Reuters) - French pharma company Ipsen expects to bring more drugs to combat cancer, rare diseases and mobility impairment into its pipeline this year and has around one billion euros ($1.25 billion) for asset purchases, its chief executive sa...

Original Article: French pharma group Ipsen sees more asset purchases, U.S. growth

NEXT ARTICLE

More From BioPortfolio on "French pharma group Ipsen sees more asset purchases, U.S. growth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...